ERBB2 and breast cancer: Furthermore, Cortazar et al. [7,8] showed that BC patients having reached pathological complete response (pCR) after NAC had higher disease-free survival (DFS) and overall survival (OS) rates, especially HER2-positive and triple negative breast cancers (TNBC).